DEF 14A

Company

Hepion Pharmaceuticals, Inc.

Filed

September 7, 2021

Period of Report

October 7, 2021

Accession Number

0001104659-21-113008

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →